AU2002325220A1 - Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol - Google Patents
Drop-forming ophthalmic gel preparation comprising diclofenamide and timololInfo
- Publication number
- AU2002325220A1 AU2002325220A1 AU2002325220A AU2002325220A AU2002325220A1 AU 2002325220 A1 AU2002325220 A1 AU 2002325220A1 AU 2002325220 A AU2002325220 A AU 2002325220A AU 2002325220 A AU2002325220 A AU 2002325220A AU 2002325220 A1 AU2002325220 A1 AU 2002325220A1
- Authority
- AU
- Australia
- Prior art keywords
- diclofenamide
- timolol
- drop
- gel preparation
- ophthalmic gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2002/005738 WO2003099258A1 (en) | 2002-05-24 | 2002-05-24 | Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002325220A1 true AU2002325220A1 (en) | 2003-12-12 |
Family
ID=29558277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002325220A Abandoned AU2002325220A1 (en) | 2002-05-24 | 2002-05-24 | Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1507513A1 (en) |
AU (1) | AU2002325220A1 (en) |
CA (1) | CA2481394A1 (en) |
WO (1) | WO2003099258A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL168603A (en) * | 2005-05-16 | 2011-05-31 | Resdevco Res And Dev Co | Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells |
US10183076B2 (en) | 2005-05-16 | 2019-01-22 | Resdevco Research And Development Co. L | Topical compositions for treatment of irritation of mucous membranes |
MX2012010684A (en) | 2010-03-17 | 2012-11-06 | Novaliq Gmbh | Pharmaceutical composition for treatment of increased intraocular pressure. |
MX361681B (en) | 2012-01-23 | 2018-12-13 | Novaliq Gmbh | Stabilised protein compositions based on semifluorinated alkanes. |
PL2895144T3 (en) | 2012-09-12 | 2017-07-31 | Novaliq Gmbh | Semifluorinated alkane compositions |
DK3355990T3 (en) | 2015-09-30 | 2019-09-16 | Novaliq Gmbh | SEMIFLUORINATED COMPOUNDS AND THEIR COMPOSITIONS |
CA3036306C (en) | 2016-09-23 | 2024-05-14 | Novaliq Gmbh | Ophthalmic compositions comprising ciclosporin |
WO2019063551A1 (en) | 2017-09-27 | 2019-04-04 | Novaliq Gmbh | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
CN111182893A (en) | 2017-10-04 | 2020-05-19 | 诺瓦利克有限责任公司 | Ophthalmic composition comprising F6H8 |
WO2019166631A1 (en) | 2018-03-02 | 2019-09-06 | Novaliq Gmbh | Pharmaceutical compositions comprising nebivolol |
SG11202007860XA (en) * | 2018-03-28 | 2020-09-29 | Novaliq Gmbh | Pharmaceutical composition comprising timolol |
JP2021522219A (en) | 2018-04-27 | 2021-08-30 | ノバリック ゲーエムベーハー | Ophthalmic composition containing tafluprost for the treatment of glaucoma |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ192673A (en) * | 1979-02-02 | 1984-07-06 | Merck & Co Inc | Ophthalmic compositions for lowering intraocular pressure |
EP0033042B1 (en) * | 1980-01-28 | 1984-08-22 | Merck & Co. Inc. | Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors |
US4678855A (en) * | 1985-10-09 | 1987-07-07 | Merck & Co., Inc. | Substituted benzenesulfonamides |
US6159458A (en) * | 1997-11-04 | 2000-12-12 | Insite Vision | Sustained release ophthalmic compositions containing water soluble medicaments |
AU2001231683A1 (en) * | 2000-01-20 | 2001-07-31 | Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh | Diclofenamide suspension gel |
-
2002
- 2002-05-24 WO PCT/EP2002/005738 patent/WO2003099258A1/en not_active Application Discontinuation
- 2002-05-24 EP EP02758204A patent/EP1507513A1/en not_active Withdrawn
- 2002-05-24 CA CA002481394A patent/CA2481394A1/en not_active Abandoned
- 2002-05-24 AU AU2002325220A patent/AU2002325220A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2481394A1 (en) | 2003-12-04 |
WO2003099258A1 (en) | 2003-12-04 |
EP1507513A1 (en) | 2005-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003225171A1 (en) | Hydrophilic polymers and methods of preparation | |
AU2003270593A1 (en) | Devices and methods for improving vision | |
AU2003233069A1 (en) | Gel and powder making | |
AU2002325220A1 (en) | Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol | |
AU2002350079A1 (en) | Gel composition and methods of use | |
AU2002341511A1 (en) | Macroporous gel, its preparation and its use | |
AU2003277910A1 (en) | Ocular gene therapy | |
AU2003260689A1 (en) | Delivery of ophthalmic lenses | |
AU2003269018A1 (en) | Acylaminothiazole derivatives, preparation and therapeutic use thereof | |
AU2003268119A1 (en) | Intelligent patient interface for ophthalmic instruments | |
AU2003269266A1 (en) | Transparent gel composition, for the administration of diclofenac sodium through the skin | |
AU2003236076A1 (en) | Hydrophilic polymers-flavonoids conjugates and pharmaceutical compositions comprising them | |
AU2003226899A1 (en) | Human diabetes-mediating proteins | |
AU2002360752A1 (en) | Viscoelastics for ocular surgery | |
AU2003236278A1 (en) | Gel food | |
AU2002321563A1 (en) | Ophthalmic devices and procedures | |
AU2003904303A0 (en) | Nerve function and tissue healing | |
AU2003900495A0 (en) | Aroylhydrazone derivatives and therapeutic uses thereof | |
AU2003263895A1 (en) | Contraceptive methods and formulations | |
AU2002350828A1 (en) | Use of dendrimers in an ophthalmic composition | |
AU2002307864A1 (en) | Alginate gel | |
AU2003296060A1 (en) | Ophthalmic therapeutic composition | |
AU2003235326A1 (en) | External preparation for allergic diseases | |
AU2002315931A1 (en) | Heterodimeric conjugates of neomycin-oxazolidinone, their preparation and their use | |
AU2003905863A0 (en) | Medicated Gel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |